Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Patient Access and Commercial Planning
-
Stock Symbol
-
MREO on Nasdaq
Alexandra Hughes-Wilson - trading volume in the past year for Mereo BioPharma Group plc
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| American Depositary Shares representing Ordinary Shares |
50.5K |
$213K |
$4.22 |
Sep 13, 2024 |
Direct |
|
|
| Share Options (Right to buy) |
0 |
$0 |
$1.01 |
Sep 11, 2024 |
Direct |
American Depository Shares |
|
| Performance Based Restricted Stock Unit |
0 |
|
|
Sep 11, 2024 |
Direct |
American Depository Shares |
|
Transactions reported by Alexandra Hughes-Wilson for Mereo BioPharma Group plc
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.